Conversely, SNX17 overexpression-induced promotion of cell proliferation, migration and invasion could be attenuated by STAT3 inhibitor BP-1-102 in HCC cells (Figure 7H-7K, Supplementary Figure S15D-S15F, Figure S15H). Here, STAT3 is linked to hepatocellular carcinoma.